Loading company details...
Latest Form 4 (Nov 12, 2026): Gary K. Lee (Chief Scientific Officer): Sale of 129 shares, $2.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 12, 2026 | Gary K. Lee, Chief Scientific Officer | Sale | 129 | $2.1K |
| Nov 12, 2026 | Stephen J. Hill, Chief Operating Officer | Sale | 88 | $1.4K |
| Nov 12, 2026 | Lynn Seely, President and CEO | Sale | 545 | $8.7K |
| Nov 12, 2026 | Veronica Sanchez Bulis, VP, Corporate Controller | Sale | 416 | $6.6K |
| Nov 5, 2026 | ARCH Venture Partners IX, LLC | Purchase | 2,321,262 | $25.00M |
| Nov 5, 2026 | ARCH Venture Fund XIII, L.P. | Purchase | 2,321,262 | $25.00M |
| Oct 13, 2026 | Jarrad Mattieu Aguirre, Chief Medical Officer | Sale | 422 | $3.6K |
| Sep 10, 2026 | David Shook, Chief Medical Officer | Sale | 500 | $6.3K |
| Sep 10, 2026 | Jarrad Mattieu Aguirre, Chief Medical Officer | Grant/Award | 47,500 | n/a |
| Aug 25, 2026 | Lynn Seely, President and CEO | Sale | 9,589 | $149.0K |